Kaplan–Meier curves for the time until development of microscopic polyangiitis (MPA) in patients with idiopathic pulmonary fibrosis according to antineutrophil.

Slides:

Advertisements

Similar presentations

Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

Advertisements

Visual analogue scale (VAS) for pain on different procedures.

Nat. Rev. Rheumatol. doi: /nrrheum

The significantly different metabolites between the systemic inflammatory response syndrome SIRS (n=15) and sepsis (n=35) groups (A); the sepsis (n=10)

Nat. Rev. Rheumatol. doi: /nrrheum

Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.

Kaplan–Meier curves of 12-month survival after an index chronic obstructive pulmonary disease-related hospitalisation according to level of moderate and.

Kaplan–Meier curves for a, b) progression-free survival (PFS) and c, d) overall survival (OS) in a, c) large-cell neuroendocrine carcinoma patients and.

(A) Changes in plaque and gingival index (Silness and Löe)21 for patients 1–8 over a 7-day period using oral hygiene intervention either with a toothbrush.

Image of the form used by ambulance officers to triage patients with an exacerbation of chronic obstructive pulmonary disease (COPD). GP, general practitioner;

Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.

Kaplan–Meier curve for the time until the development of lung cancer in patients with idiopathic pulmonary fibrosis. Kaplan–Meier curve for the time until.

Consolidated Standards of Reporting Trials diagram

The top 25 analytes by relevant q-value differentially expressed in HIV with COPD. The top number is m/z and the bottom number is RT. Y-axis is intensity.

Nat. Rev. Rheumatol. doi: /nrrheum

Kaplan–Meier survival curves of overall survival (OS) for EGFR mutant lung adenocarcinoma patients who received epidermal growth factor receptor tyrosine.

Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.

For most patients with asthma airway response becomes flatter after 1000 µg of inhaled corticosteroid, but systemic activity (measured by serum cortisol.

Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.

Serum levels of angiopoietin-like protein 4 (ANGPTL4) according to patients with chronic obstructive pulmonary disease and controls without any lung disease.

Percentage of patients per stage of oesophageal cancers in the two trials, overall difference P

(A–C) Electron microscopic images obtained from two different cases, (A) a cluster of large malignant cells with cytoplasmic mucin vacuoles consistent.

Comparison of the age-associated prevalence (y axis) in the Catalan Healthcare Surveillance System (CHSS) and Medicare datasets of selected disease groups.

Change from baseline in the severity of night-time cough and the frequency of night-time sputum production at week 12 in ACCORD COPD I.17 Data are reported.

Kaplan–Meier curves of long-term survival in young (

Comparison of the bronchoalveolar lavage fluid (BALF) levels of the three vascular endothelial growth factor (VEGF) types in healthy volunteers and patients.

(A) Temporal order of pairwise diagnoses in patients with chronic obstructive pulmonary disease (COPD). (A) Temporal order of pairwise diagnoses in patients.

Patients’ pathways to Accident and Emergency (A&E)

Incidence of choking in London, UK, by gender per 1000 population by age group. Incidence of choking in London, UK, by gender per 1000 population by age.

Peripheral blood eosinophil levels based on a threshold of (A) 150 cells/μL, patients not randomised to inhaled corticosteroids (ICS)-containing treatment.

Use of medication among chronic obstructive pulmonary disease (COPD) cases by age and place of residence among 1586 COPD cases. The dark grey bar represents.

Change from baseline in the severity of morning cough and severity of difficulty bringing up phlegm in the morning over the study period in the active-comparator.

Patient case study 2—fibrotic uILD in the setting of IPAF

Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by age, and place of residence. The dark grey bar represents ‘rural’

Accuracy of sputum colour in predicting NB

Forest plots for randomised and cluster randomised controlled trials from Cochrane review Biomarkers as point-of-care tests to guide prescription of antibiotics.

Comparison of the serum levels of the three vascular endothelial growth factor (VEGF) types in healthy volunteers and patients with idiopathic pulmonary.

Flow diagram demonstrating the management of close contacts of pulmonary TB cases diagnosed at Parramatta Chest Clinic, Sydney, Australia. *None of the.

Kaplan–Meier curves for the time until myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-positive conversion (A: MPO-ANCA, B: proteinase 3.

Receiver under the operator characteristic (ROC) curve for the test accuracy of the final risk score in the entire external validation sample (c statistic=0.84,

Changes in median exhaled CO levels from baseline to 12 weeks in quitters (n=183) and continuous smokers (n=94). Changes in median exhaled CO levels from.

Changes in St. George's Respiratory Questionnaire (SGRQ) scores from baseline to 12 weeks for total samples (n=277), quitters (n=183) and continuous smokers.

Comparative receiver operating characteristic (ROC) curves and the area under the curve (AUC) in association with 30-day mortality for severity scores.

Transit time technique: (A) axial HASTE through the pulmonary trunk bifurcation; (B) short axis RPA; (C) short axis MPA; (D) short axis LPA; (E) flow curves.

Receiver operating characteristic curves (ROC) for the metabolites between the systemic inflammatory response syndrome (n=15) and sepsis (n=35) groups.

Kaplan–Meier curves for the time until development of microscopic polyangiitis (MPA) (A) and for survival (B) in myeroperoxidase-antineutrophil cytoplasmic.

Typical liquid chromatography–mass spectrometry spectra of sera from patients with sepsis (A) or systemic inflammatory response syndrome (SIRS) (B) and.

Worse eDiary scores are associated the more rescue inhaler usage and reduced step counts over both an individual day and 3-week summary period. Worse eDiary.

Plot of change in incremental shuttle walk test following pulmonary rehabilitation according to ACE (insertion/deletion) polymorphism. Plot of change in.

Vitamin D status versus acute respiratory failure Rate

Manhattan plot for the association between COPD and DNA methylation in never smokers (left) and current smokers (right). Manhattan plot for the association.

Changes in 6 min walk distance (6MWD) for combined pulmonary fibrosis and emphysema (CPFE) (n=15), and chronic obstructive pulmonary disease (COPD) (n=37).

Prevalence of air flow obstruction (age-adjusted) by (A) lower limit of normal of forced expiratory ratio versus self-reported doctor diagnosis and (B)

Receiver operating characteristic ROC curve of Lung Clearance Index (LCI)1/40, LCI1/30, LCI1/20, LCI1/10 and inverse forced expiratory volume in 1 s %

Screening test accuracy of the final risk score at a threshold of ≥2

Reclined functional residual capacity (FRC) predicts cough inspired volume, which in turn predicts cough flow. Reclined functional residual capacity (FRC)

HFNC off is compared with HFNC 30 L/min and HFNC 50 L/min for tidal volume. HFNC off is compared with HFNC 30 L/min and HFNC 50 L/min for tidal volume.

Survival curves according to the presence of late gadolinium enhancement (LGE) and elevated high-sensitivity C reactive protein (hs-CRP). Survival curves.

Weekly bronchitis cases (circles, left hand axis) and particulate matter with a diameter below 10 µ (PM10) (crosses, right hand axis), with smoothed curves.

COPD Action Plan adherence.

Frequency of PR3-ANCA and MPO-ANCA positivity in ANCA-positive patients with a particular organ system involvement in an inception cohort of 502 ANCA vasculitis.

Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by region. The dark grey bar represents ‘symptom-based COPD’,

Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

Comparison of the serum and bronchoalveolar lavage fluid (BALF) levels of CCL21 among healthy volunteers and patients with idiopathic pulmonary fibrosis.

Accuracy of sputum colour in predicting neutrophilic inflammation.

Comparison of reclined functional residual capacity (FRC) in stroke patients and controls. Comparison of reclined functional residual capacity (FRC) in.

The association between age and CFQ-R total score (left) and medical status (standardised to mean zero and SD one) (right) for patients homozygous or compound.

Subtypes of ILD in pre-MDT and post-MDT cohorts.

ICU length of stay comparing LTV and HTV mechanical ventilation in adult patients with ARDS. ARDS, acute respiratory distress syndrome; HTV, higher tidal.

Receiver operating characteristic (ROC) curves for Saint George’s Respiratory Questionnaire (SGRQ) category scores predicting chronic obstructive pulmonary.

Presentation transcript:

Kaplan–Meier curves for the time until development of microscopic polyangiitis (MPA) in patients with idiopathic pulmonary fibrosis according to antineutrophil cytoplasmic antibody (ANCA) positivity at diagnosis. Kaplan–Meier curves for the time until development of microscopic polyangiitis (MPA) in patients with idiopathic pulmonary fibrosis according to antineutrophil cytoplasmic antibody (ANCA) positivity at diagnosis. The log-rank test showed the difference between ANCA-negative patients and myeloperoxidase (MPO)-ANCA-positive patients to be significant (p<0.001). PR3, proteinase 3. Naho Kagiyama et al. BMJ Open Resp Res 2015;2:e000058 ©2015 by British Thoracic Society